<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37406070</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1972-2680</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of infection in developing countries</Title><ISOAbbreviation>J Infect Dev Ctries</ISOAbbreviation></Journal><ArticleTitle>A study of long COVID-19 in Duhok, Kurdistan region, Iraq.</ArticleTitle><Pagination><StartPage>805</StartPage><EndPage>811</EndPage><MedlinePgn>805-811</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3855/jidc.17468</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Long COVID-19 refers to a range of symptoms and complications that persist after being infected with COVID-19 or develop some time after recovery. Our study aimed at assessing the prevalence of long COVID-19 in Duhok city, Iraq and its correlation with epidemiological and clinical variables.</AbstractText><AbstractText Label="METHODOLOGY">This cross-sectional study was conducted between March and August 2022. A questionnaire was used for data collection from participants aged 18 and older. The questionnaire included demographic information and clinical data.</AbstractText><AbstractText Label="RESULTS">Among the 1039 participants, (49.7%) were male with a mean age of 34.048 &#xb1; 13 years. Total infected volunteers were 492 (47.4%), out of which 20.7% did not have long COVID-19 and 26.7% had long COVID-19. The most common long COVID-19 manifestations were fatigue (57%), hair loss (39%) and loss/change in the sense of smell or taste (35%). Correlation between the variables gender, comorbidities, age, and duration of infection, and long COVID-19 were significant (p values = 0.016, 0.018, 0.001, and 0.001 respectively).</AbstractText><AbstractText Label="CONCLUSIONS">There was a significant correlation between long COVID-19 cases and age, gender, comorbidities, and duration of infection. The data of this report can be used as a baseline for studies that may help further understand long COVID-19 sequelae.</AbstractText><CopyrightInformation>Copyright (c) 2023 Salmas S Ahmed, Pawan I Adil, Narin A Rasheed, Nawfal R Hussein, Kuldeep Dhama.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Salmas S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine, University of Zakho, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adil</LastName><ForeName>Pawan I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine, University of Zakho, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasheed</LastName><ForeName>Narin A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Technology, College of Health and Medical Technology-Shekhan, Duhok Polytechnic University, Duhok, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Nawfal R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine, University of Zakho, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhama</LastName><ForeName>Kuldeep</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pathology, ICAR-Indian Veterinary Research Institute (IVRI), Izatnagar, Bareilly, Uttar Pradesh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>J Infect Dev Ctries</MedlineTA><NlmUniqueID>101305410</NlmUniqueID><ISSNLinking>1972-2680</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007493" MajorTopicYN="N" Type="Geographic">Iraq</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Duhok</Keyword><Keyword MajorTopicYN="N">Iraq</Keyword><Keyword MajorTopicYN="N">comorbidities</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword></KeywordList><CoiStatement>No Conflict of Interest is declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37406070</ArticleId><ArticleId IdType="doi">10.3855/jidc.17468</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>